The Rotavirus vaccine currently included in India's UIP schedule is an oral vaccine administered at 6, 10, and 14 weeks. The vaccine used is:

• A Rotarix (G1P[8] human strain)
• B ROTAVAC (116E strain, indigenous single-strain vaccine) ✓
• C RotaTeq (bovine-human pentavalent reassortant)
• D ROTASIIL (pentavalent bovine-human reassortant, IIAB)

Explanation

ROTAVAC, developed by Bharat Biotech in collaboration with AIIMS and international partners, uses the neonatal 116E strain (G9P[11]) isolated from a neonatal Delhi nursery. It is the primary rotavirus vaccine introduced into India's UIP. ROTASIIL (another indigenous pentavalent vaccine) is WHO-prequalified but was introduced later. Rotarix and RotaTeq are used in other countries' programmes but are not part of India's current UIP schedule.

Reference: Park's Textbook of Preventive and Social Medicine, 27th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.